Microbiology and Immunology

You are here

Publications

Found 67 results

] Title Type Year

Filters: First Letter Of Last Name is K [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

K

Klotzsche M, Ehrt S, Schnappinger D. 2009. Improved tetracycline repressors for gene silencing in mycobacteria.. Nucleic Acids Res. 37(6):1778-88.

Klasse PJohan, Sanders RW, Cerutti A, Moore JP. 2012. How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development? AIDS Res Hum Retroviruses. 28(1):1-15.

Klasse PJ, Ketas TJ, Cottrell CA, Ozorowski G, Debnath G, Camara D, Francomano E, Pugach P, Ringe RP, LaBranche CC et al.. 2018. Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques.. PLoS Pathog. 14(2):e1006913.

Klasse PJohan, Shattock R, Moore JP. 2008. Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission.. Annu Rev Med. 59:455-71.

Kishore SP, Perkins SL, Templeton TJ, Deitsch KW. 2009. An unusual recent expansion of the C-terminal domain of RNA polymerase II in primate malaria parasites features a motif otherwise found only in mammalian polymerases.. J Mol Evol. 68(6):706-14.

Kishore SP, Stiller JW, Deitsch K. 2013. Horizontal gene transfer of epigenetic machinery and evolution of parasitism in the malaria parasite Plasmodium falciparum and other apicomplexans.. BMC Evol Biol. 13:37.

Kirkman L, Deitsch K. 2012. Antigenic variation and the generation of diversity in malaria parasites.. Curr Opin Microbiol. 15(4):456-62.

Kirkman LA, Deitsch KW. 2020. Vive la Différence: Exploiting the Differences between Rodent and Human Malarias.. Trends Parasitol. 36(6):504-511.

Kirkman LA, Zhan W, Visone J, Dziedziech A, Singh PK, Fan H, Tong X, Bruzual I, Hara R, Kawasaki M et al.. 2018. Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance.. Proc Natl Acad Sci U S A. 115(29):E6863-E6870.

Kirkman L, Lawrence EA, Deitsch K. 2014. Malaria parasites utilize both homologous recombination and alternative end joining pathways to maintain genome integrity.. Nucleic Acids Res. 42(1):370-9.

Kirk BW, Feinsod M, Favis R, Kliman RM, Barany F. 2002. Single nucleotide polymorphism seeking long term association with complex disease.. Nucleic Acids Res. 30(15):3295-311.

Kim J-H, Wei J-R, Wallach JB, Robbins RS, Rubin EJ, Schnappinger D. 2011. Protein inactivation in mycobacteria by controlled proteolysis and its application to deplete the beta subunit of RNA polymerase.. Nucleic Acids Res. 39(6):2210-20.

Kim S, Chung EY, Ma X. 2005. Immunological consequences of macrophage-mediated clearance of apoptotic cells.. Cell Cycle. 4(2):231-4.

Kim H-J, Lv D, Zhang Y, Peng T, Ma X. 2012. Golgi phosphoprotein 2 in physiology and in diseases.. Cell Biosci. 2(1):31.

Kim H, Zhao Q, Zheng H, Li X, Zhang T, Ma X. 2015. A novel crosstalk between TLR4- and NOD2-mediated signaling in the regulation of intestinal inflammation.. Sci Rep. 5:12018.

Kim BS, Siracusa MC, Saenz SA, Noti M, Monticelli LA, Sonnenberg GF, Hepworth MR, Van Voorhees AS, Comeau MR, Artis D. 2013. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation.. Sci Transl Med. 5(170):170ra16.

Kim J-H, O'Brien KM, Sharma R, Boshoff HIM, Rehren G, Chakraborty S, Wallach JB, Monteleone M, Wilson DJ, Aldrich CC et al.. 2013. A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence.. Proc Natl Acad Sci U S A. 110(47):19095-100.

Kim S, Elkon KB, Ma X. 2004. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells.. Immunity. 21(5):643-53.

Kim SJun, Gershov D, Ma X, Brot N, Elkon KB. 2002. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation.. J Exp Med. 196(5):655-65.

Kim SJung, Gershov D, Ma X, Brot N, Elkon KB. 2003. Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses.. Ann N Y Acad Sci. 987:68-78.

Ketas TJ, Schader SM, Zurita J, Teo E, Polonis V, Lu M, Klasse PJohan, Moore JP. 2007. Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.. Virology. 364(2):431-40.

Ketas TJ, Holuigue S, Matthews K, Moore JP, Klasse PJohan. 2012. Env-glycoprotein heterogeneity as a source of apparent synergy and enhanced cooperativity in inhibition of HIV-1 infection by neutralizing antibodies and entry inhibitors.. Virology. 422(1):22-36.

Kathpalia VP, Mussak EN, Chow SS, Lam PH, Skelley N, Time M, Markelewicz RJ, Kanduc D, Lomas L, Xiang Z et al.. 2006. Genome-wide transcriptional profiling in human squamous cell carcinoma of the skin identifies unique tumor-associated signatures.. J Dermatol. 33(5):309-18.

Kass-Eisler A, Leinwand L, Gall J, Bloom B, Falck-Pedersen E. 1996. Circumventing the immune response to adenovirus-mediated gene therapy.. Gene Ther. 3(2):154-62.

Kass-Eisler A, Falck-Pedersen E, Alvira M, Rivera J, Buttrick PM, Wittenberg BA, Cipriani L, Leinwand LA. 1993. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo.. Proc Natl Acad Sci U S A. 90(24):11498-502.